Skip to main content

Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.

As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.

 

Marijuana Use During the COVID-19 Pandemic

July 8, 2021

Dr. Steven J. Rigatti explores marijuana use during the COVID-19 pandemic as a follow-up to earlier commentary on alcohol and tobacco use…. Read More

Tags: Alcohol, Covid 19, Laboratory, Marijuana, Pandemic

Recent Publication on Mortality: Impacts on Insurers

June 28, 2021

Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More

Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement

2020 US Mortality Results: How do they compare to prior years?

June 17, 2021

Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More

Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality

The Emerging Marijuana Challenge: Δ8-THC

May 18, 2021

Delta-8 Compound Marijuana testing is used by a number of life insurers in the risk assessment process. New chemical entities… Read More

Tags: Delta 8 Thc, Drug Test, Insurance, Laboratory, Marijuana

Urine Protein Tests: A Mortality Predictor in Life Insurance Populations

March 31, 2021

Urine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently… Read More

Tags: Healthcare, Kidney, Life Insurance, Medical Research, Mortality

Bad Habits and the Pandemic

March 10, 2021

Dr. Steven Rigatti, Consulting Medical Director to CRL, comments on alcohol and tobacco usage rates from a pre-pandemic period to… Read More

Tags: Alcohol, Covid 19, Covid 19 Crisis, Pandemic, Stay At Home

New CRL COVID-19 Research: Viral Load in Asymptomatic vs. Symptomatic Cases is Similar

February 22, 2021

A new paper on COVID-19 research from CRL doctors was published this week. Over 460k samples collected from July 2020… Read More

Tags: Covid 19, Covid 19 Crisis, Covid 19 Testing, Covid Update, Data

Trends in Nicotine Misrepresentation

January 20, 2021

A fundamental underwriting principal is to treat like risks in a similar manner. This fairness doctrine is a key to… Read More

Tags: Cigarettes, Insurance, Mortality, Nicotine, Risk

COVID-19 Antibody Prevelance Increased throughout 2020: New Research from CRL

January 7, 2021

Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management

CRL Acquires Confirm BioSciences

December 14, 2020

See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired Confirm BioSciences, a… Read More

Tags: Acquisition, Business, Laboratory, Life Insurance, Mortality